- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4015 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Patent holdings for IPC class A61K 31/4015
Total number of patents in this class: 1344
10-year publication summary
|
79
|
106
|
111
|
96
|
108
|
127
|
98
|
106
|
80
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 146 |
36 |
| Allergan, Inc. | 2198 |
22 |
| The Johns Hopkins University | 5844 |
22 |
| University of Southern California | 2123 |
22 |
| Jazz Pharmaceuticals Research UK Limited | 254 |
20 |
| The Regents of the University of California | 20590 |
19 |
| Bristol-myers Squibb Company | 4789 |
17 |
| Agenebio, Inc. | 45 |
13 |
| Daewoong Pharmaceutical Co., Ltd. | 350 |
13 |
| Pfizer Inc. | 3375 |
12 |
| Ovid Therapeutics Inc | 173 |
11 |
| UCB Pharma S.A. | 223 |
11 |
| Cayman Chemical Company, Incorporated | 64 |
10 |
| University of Massachusetts | 2300 |
9 |
| Novartis AG | 10338 |
8 |
| Janssen Pharmaceutica N.V. | 3213 |
8 |
| Alkermes Pharma Ireland Limited | 256 |
8 |
| Laboratori Baldacci SpA | 30 |
8 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 295 |
8 |
| Azura Ophthalmics Ltd. | 83 |
8 |
| Other owners | 1059 |